Precision Epigenetics: Targeting The Epigenome To Treat Disease
Funder
National Health and Medical Research Council
Funding Amount
$1,940,576.00
Summary
Epigenetic marks are changes made to the DNA that allow genes to be switched off in some cells and switched on in others. These marks are critical to normal development and often go wrong in disease. We aim to find genes that add epigenetic marks to the DNA and understand how they co-operate at the molecular level to switch genes off. Our focus is on one such gene, SMCHD1. We are developing new drugs against SMCHD1 to treat incurable neurodevelopmental disorder PWS and muscular dystrophy FSHD.
Closing The Clinical Translation Gap Of The Gut Microbiome In Chronic Diseases
Funder
National Health and Medical Research Council
Funding Amount
$1,337,350.00
Summary
The gut microbiota is important for human health and disease but knowledge transfer to clinical practice is lacking. This proposal will investigate how diet & gut microbiota changes connect with physical symptoms, mental health & behavioural issues in chronic diseases, using cystic fibrosis & autism spectrum disorder as models of disease. Improved understanding can improve management, assist in developing targeted therapies & is key to providing real-world solutions to improve outcomes.
A Network Approach To Mapping And Modifying Brain Changes In Psychosis
Funder
National Health and Medical Research Council
Funding Amount
$2,163,245.00
Summary
Psychosis fundamentally alters a person’s relationship with reality. Brain scans can map which parts of the brain are affected by psychosis, but they cannot reveal the actual disease processes that cause these changes. I will address this gap by integrating brain imaging with genetics and mathematical modelling to identify the brain circuits and molecules that impact risk for psychosis, and to develop targeted therapies that modify risk-related brain dysfunction.